April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Change in Diurnal Fluctuation of Pulsatile Ocular Parameters in the DIOXXACT Study (Diurnal IOP and OBF Xalatan vs. Xalatan And Cosopt Trial)
Author Affiliations & Notes
  • Denise Descovich
    Ophthalmology,
    Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
  • Paul Harasymowycz
    Ophtalmology,
    Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Montreal University, Montreal, Quebec, Canada
  • Mark R. Lesk
    Ophtalmology,
    Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
    Ophthalmology, Montreal University, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships  Denise Descovich, None; Paul Harasymowycz, None; Mark R. Lesk, None
  • Footnotes
    Support  Merk Frost Canada
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3488. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Denise Descovich, Paul Harasymowycz, Mark R. Lesk; Change in Diurnal Fluctuation of Pulsatile Ocular Parameters in the DIOXXACT Study (Diurnal IOP and OBF Xalatan vs. Xalatan And Cosopt Trial). Invest. Ophthalmol. Vis. Sci. 2011;52(14):3488. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Diurnal fluctuations in IOP are strongly associated with progression of open angle glaucoma. Our goal was to monitor diurnal fluctuations in IOP and choroidal blood flow when Cosopt was added to patients under Xalatan monotherapy.

Methods: : Measurements were performed on 17 open angle glaucoma patients on Xalatan monotherapy. All patients have undergone a complete diurnal workup at 8am, 10am, 2pm, and 4pm including IOP and Pulse amplitude (OPA) measured with the Pascal Dynamic Contour Tonometer and Choroidal blood flow measured in the sub-foveolar choroid using single-point laser Doppler flowmetry (Oculix). The pulsatility of VEL, VOL and FLO was determined with automated software using for example, the formula (systolic VEL- diastolic VEL) / systolic VEL. Cosopt has been added and the same measures were repeated 6 weeks later.

Results: : After the addition of Cosopt, mean IOP measured with the Pascal showed a significant reduction (from 18.14 ± 3.5 to 15.52 ± 2.1mmHg) (p<0.01) as well as the mean OPA (2.64 ± 0.8 to 2.24 ± 0.9mmHg) (p<0.01). The mean pulsatility of volume at the choroid has decreased with the addition of Cosopt, but not significantly (from 0.433 ± 0.187 to 0.365 ± 0.121).

Conclusions: : Adding Cosopt to patients on Xalatan monotherapy has reduced significantly the IOP and Pulsatility. However, pulsatile choroidal flowmetry measurements were not significantly reduced in this sample.

Clinical Trial: : http://www.clinicaltrials.gov 157-00

Keywords: clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • intraocular pressure • optic flow 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×